BR112012028146A2 - compostos de peróxido orgânico para inativação de microorganismos - Google Patents

compostos de peróxido orgânico para inativação de microorganismos

Info

Publication number
BR112012028146A2
BR112012028146A2 BR112012028146A BR112012028146A BR112012028146A2 BR 112012028146 A2 BR112012028146 A2 BR 112012028146A2 BR 112012028146 A BR112012028146 A BR 112012028146A BR 112012028146 A BR112012028146 A BR 112012028146A BR 112012028146 A2 BR112012028146 A2 BR 112012028146A2
Authority
BR
Brazil
Prior art keywords
organic peroxide
inactivation
microorganisms
peroxide compounds
organic
Prior art date
Application number
BR112012028146A
Other languages
English (en)
Portuguese (pt)
Inventor
Jens Peter Gregersen
Thomas Grundemann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR112012028146A2 publication Critical patent/BR112012028146A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02Acyclic compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/02Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/24Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12061Methods of inactivation or attenuation
    • C12N2720/12063Methods of inactivation or attenuation by chemical treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16061Methods of inactivation or attenuation
    • C12N2760/16063Methods of inactivation or attenuation by chemical treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161Methods of inactivation or attenuation
    • C12N2760/16163Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polymerization Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112012028146A 2010-05-06 2011-05-06 compostos de peróxido orgânico para inativação de microorganismos BR112012028146A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39511710P 2010-05-06 2010-05-06
PCT/IB2011/001394 WO2011138682A2 (en) 2010-05-06 2011-05-06 Organic peroxide compounds for microorganism inactivation

Publications (1)

Publication Number Publication Date
BR112012028146A2 true BR112012028146A2 (pt) 2015-09-15

Family

ID=44532956

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012028146A BR112012028146A2 (pt) 2010-05-06 2011-05-06 compostos de peróxido orgânico para inativação de microorganismos

Country Status (11)

Country Link
US (1) US9426989B2 (enExample)
EP (1) EP2566323A2 (enExample)
JP (1) JP6072677B2 (enExample)
KR (1) KR20130079398A (enExample)
CN (1) CN102946727B (enExample)
AU (1) AU2011249487C1 (enExample)
BR (1) BR112012028146A2 (enExample)
CA (1) CA2796213A1 (enExample)
EA (1) EA201291179A1 (enExample)
MX (1) MX343948B (enExample)
WO (1) WO2011138682A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883848B2 (en) 2011-07-14 2014-11-11 Ecolab Usa Inc. Enhanced microbial peracid compositions and methods of use at reduced temperatures in aseptic cleaning
US8906963B2 (en) 2011-07-14 2014-12-09 Ecolab Usa Inc Deodorization of peracids
GB2495341B (en) 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
ITUA20162517A1 (it) * 2016-04-12 2017-10-12 Andrea Fantozzi Composizione per la conservazione/fissazione di materiale biologico
CA3080656A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN110804641A (zh) * 2019-09-04 2020-02-18 中国农业科学院兰州兽医研究所 一种比较分析不同牛支原体菌株毒力的方法
AU2020380604A1 (en) 2019-11-07 2022-06-09 Seqirus UK Limited Compositions and methods for producing a viral vaccine with reduced particle size

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL288026A (enExample) * 1963-01-16
US3560395A (en) * 1968-09-12 1971-02-02 Pennwalt Corp Aqueous ketone peroxide-hydrogen peroxide composition
US4060644A (en) * 1976-02-09 1977-11-29 Interox Chemicals Limited Bleaching
DE2933498A1 (de) 1979-08-18 1981-04-09 Dr.rer.nat. Hans-Dieter 4234 Alpen Deppe Chemothermisches desinfektions- und sterilisationsverfahren
PH25669A (en) * 1985-12-19 1991-09-04 Padmini Sampathkumar Anaerobe-selective antibacterial compositions, methods
EP0461700A1 (en) 1990-06-12 1991-12-18 Akzo Nobel N.V. Aqueous disinfectant compositions, and concentrates for preparing the same
US5437868A (en) * 1991-07-23 1995-08-01 Ecolab Inc. Peroxyacid antimicrobial composition
GB9222561D0 (en) * 1992-10-27 1992-12-09 Ici Plc Macromolecular degradation
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
FR2738127B1 (fr) 1995-08-30 1998-03-27 Oreal Applicateur de mascara
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
GB9612035D0 (en) * 1996-06-08 1996-08-07 Oilfield Chemical Additives Li Method of inhibiting reservoir souring by bacteria
DE19817743A1 (de) * 1998-04-21 1999-10-28 Binker Materialschutz Gmbh Materialschutzmittel
AU758625B2 (en) 1998-08-20 2003-03-27 Ecolab Inc. The treatment of meat products
NZ517903A (en) 1999-09-24 2003-10-31 Smithkline Beecham Biolog S One dose intranasal influenza virus vaccine with split influenza viral antigens
DE60142506D1 (de) 2000-03-03 2010-08-19 Chemo Sero Therapeut Res Inst In serumfreier kultur verwendbare zelle, kultursuspension und verfahren zur virusproduktion als impfstoff unter verwendung der zelle
FR2808803B1 (fr) 2000-05-11 2004-12-10 Agronomique Inst Nat Rech Cellules es modifiees et gene specifique de cellules es
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
US20020107288A1 (en) * 2000-12-08 2002-08-08 Singh Waheguru Pal Methods of sterilizing with dipercarboxylic acids
US7316824B2 (en) * 2000-12-15 2008-01-08 Ecolab Inc. Method and composition for washing poultry during processing
US20040096463A1 (en) 2001-02-23 2004-05-20 Nathalie Garcon Novel vaccine
CA2438942A1 (en) 2001-02-23 2002-09-26 Glaxosmithkline Biologicals S.A. Influenza vaccine formulations for intradermal delivery
TWI228420B (en) 2001-05-30 2005-03-01 Smithkline Beecham Pharma Gmbh Novel vaccine composition
US20030012804A1 (en) * 2001-06-22 2003-01-16 Aquacide And Use Aquacide and use
EP1420065A4 (en) * 2001-08-02 2005-03-09 Anges Mg Inc PROCESS FOR PRODUCING INACTIVE VIRAL ENVELOPES
DE10144903A1 (de) 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Vermehrung von Viren in Zellkultur
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
FR2832423B1 (fr) 2001-11-22 2004-10-08 Vivalis Systeme d'expression de proteines exogenes dans un systeme aviaire
CN1194984C (zh) * 2002-02-04 2005-03-30 中国农业科学院植物保护研究所 一种抗生素及其制备方法和应用
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
JP4299514B2 (ja) * 2002-08-29 2009-07-22 長谷川香料株式会社 抗菌抗カビ剤
DE10306018A1 (de) * 2003-02-13 2004-09-09 Siemens Ag Analyse- und Diagnostikinstrument
PT1637168E (pt) 2003-04-16 2009-04-20 Neochemical Desarrollos Avanza Uso de um peróxido de dialquil cetona como agente biocida: esterilizante, anti-séptico, desinfectante e antiparasitário
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
WO2005113756A1 (en) 2004-05-14 2005-12-01 Glaxosmithkline Biologicals S.A. Method
NZ551640A (en) 2004-05-20 2010-05-28 Id Biomedical Corp Process for the production of an influenza vaccine
CN101189326B (zh) 2004-12-23 2013-06-12 米迪缪尼有限公司 用于病毒增殖的非致瘤性mdck细胞系
GB0505909D0 (en) * 2005-03-23 2005-04-27 Univ Leeds Formulations
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
ES2423663T3 (es) * 2005-08-08 2013-09-23 Oregon Health And Science University Inactivación de patógenos con peróxido de hidrógeno para la producción de vacunas
WO2007042175A1 (en) 2005-10-07 2007-04-19 Dsm Ip Assets B.V. Peroxide decomposition catalyst
CN101365480B (zh) * 2005-11-01 2014-11-05 诺华疫苗和诊断有限两合公司 经由β-丙内酯处理的残留细胞DNA水平降低的细胞衍生病毒疫苗
ES2286949B1 (es) 2006-05-26 2008-11-01 Braulio Peña Rodriguez Uso de combinaciones de peroxido de metil etil cetona por pulverizacion.
PL2121011T3 (pl) 2006-12-06 2014-10-31 Novartis Ag Szczepionki zawierające antygeny czterech szczepów wirusa grypy

Also Published As

Publication number Publication date
EP2566323A2 (en) 2013-03-13
US20130149194A1 (en) 2013-06-13
AU2011249487C1 (en) 2015-05-14
AU2011249487B2 (en) 2014-10-02
JP2013528586A (ja) 2013-07-11
JP6072677B2 (ja) 2017-02-01
CN102946727A (zh) 2013-02-27
WO2011138682A2 (en) 2011-11-10
MX2012012335A (es) 2012-11-21
CN102946727B (zh) 2015-08-19
US9426989B2 (en) 2016-08-30
WO2011138682A3 (en) 2012-03-15
AU2011249487A1 (en) 2012-09-27
MX343948B (es) 2016-11-30
EA201291179A1 (ru) 2013-04-30
KR20130079398A (ko) 2013-07-10
CA2796213A1 (en) 2011-11-10
WO2011138682A8 (en) 2012-07-19

Similar Documents

Publication Publication Date Title
BR112012028146A2 (pt) compostos de peróxido orgânico para inativação de microorganismos
MX2015007925A (es) Nucleosidos sustituidos, nucleotidos y analogos de los mismos.
PH12015501017A1 (en) Alternative uses for hbv assembly effectors
PH12018500931A1 (en) Hcv polymerase inhibitors
EA201491505A1 (ru) Соединения для лечения спинальной мышечной атрофии
CL2017001362A1 (es) Compuestos de n-((het)arilmetil)-heteroaril-carboxamidas como inhibidores de calicreína plasmática
EA025278B9 (ru) Антивирусная композиция против заключенных или незаключенных в оболочку днк- или рнк-вирусов
CR20120440A (es) Compuestos policìclicos heterocìclicos se puede utilizar como inhibidores eficaces para virus de la hepatitis c
PH12017500207A1 (en) Indoles for use in influenza virus infection
EA030115B9 (ru) Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
PH12015500347A1 (en) 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
EA201270423A1 (ru) Ингибиторы протеазы hcv
CR20160241A (es) Nuevas dihidroquinolizinonas para el tratamiento y profilaxis de la infección por virus de la hepatitis b
CL2012000573A1 (es) Compuestos derivados de bifenil-pirrolidinil-imidazol; composicion farmaceutica que los comprende; su uso en el tratamiento de una infeccion viral por hcv.
MX2017002972A (es) Pirrolopirimidinas para usarse en la infeccion por el virus de la gripe.
MX339899B (es) Compuestos de triazolopiridina como inhibidores de pim cinasa.
BR112013005872A2 (pt) compostos, composição farmacêutica e respectivos usos
MX383447B (es) Combinación de un inhibidor de ensamblaje de cápsido y peginterferón alfa-2a y sus usos para tratar infecciones por virus de la hepatitis b (vhb).
EA201491412A1 (ru) Соединения для лечения спинальной мышечной атрофии
EA201071315A1 (ru) Ингибиторы протеазы вируса гепатита с
EP4268860A3 (en) Compositions, devices, kits and methods for attaching stent-containing medical devices to tissue
IL249136A0 (en) Recombinant bacteria capable of fixing carbon
WO2012006149A3 (en) Analogs of c5a and methods of using same
BR112012012499B8 (pt) gel de óleo contendo um líquido não polar e um pó contendo triterpeno como precursor de gel de óleo
IN2014KN02769A (enExample)

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2513 DE 06-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.